Summit Therapeutics
SMMT
SMMT
21 hedge funds and large institutions have $44.5M invested in Summit Therapeutics in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $50.9M → $44.5M (-$6.35M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.05M | |
| 2 | +$765K | |
| 3 | +$252K | |
| 4 |
First Eagle Investment Management
New York
|
+$222K |
| 5 |
Renaissance Technologies
New York
|
+$173K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.15M | |
| 3 | -$231K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$27.7K |
| 5 |
Axa
Paris,
France
|
-$2.67K |